Who Should Use Ozempic for Weight Loss?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist, reduces appetite and slows stomach emptying to support sustained weight loss. Clinical trials show participants lose 10-22% of body weight over 68 weeks. But not every person benefits equally—your genetics, health history, and lifestyle determine whether semaglutide injection is the right fit for your weight loss goals.

BMI Thresholds and Medical Eligibility for Semaglutide

Semaglutide injection is medically appropriate for adults meeting specific body mass index criteria. The FDA-approved weight-loss indication applies to people with a BMI of 30 or higher, or a BMI of 27 or higher paired with at least one weight-related condition such as type 2 diabetes, hypertension, or sleep apnea. These thresholds reflect decades of obesity research showing that weight loss at these levels meaningfully reduces cardiovascular and metabolic disease risk.

Your starting point matters because it determines your potential for improvement and your body's responsiveness to GLP-1 signaling. Someone with a BMI of 35 and prediabetes may see faster metabolic benefits than someone with a BMI of 27 and no comorbidities, though both can achieve meaningful results. PlexusDx evaluates your complete health profile—not just the number on the scale—to confirm candidacy before you start compounded semaglutide injection at just $149 per month.

Weight-Related Health Conditions That Support Semaglutide Use

Beyond BMI, certain conditions make semaglutide an especially strong choice. Type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, and cardiovascular disease all respond positively when weight loss occurs. Research shows that semaglutide users with these conditions experience improvements in blood sugar control, blood pressure, and inflammation markers within 8-12 weeks of starting therapy.

Polycystic ovary syndrome (PCOS), fatty liver disease, and chronic joint pain also improve with weight reduction via GLP-1 mechanism. If you carry weight primarily in your abdomen (visceral fat), semaglutide tends to preferentially reduce that depot, which directly lowers metabolic inflammation and disease risk. PlexusDx reviews your medical history to identify these conditions and confirm that semaglutide injection aligns with your health goals.

Genetics and Peptide Pathways: Why One Person Thrives While Another Doesn't

Your genes influence how strongly your GLP-1 receptors respond to semaglutide, how your appetite-control pathways react, and whether you carry variants that favor weight loss or metabolic resistance. Key genetic variants in GLP1R, GIPR, FTO, and MC4R pathways predict individual response patterns. Someone with a favorable GLP1R variant may see appetite suppression within days, while someone with an FTO risk variant might need a slower dose escalation to achieve the same effect.

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to map 14 different metabolic pathways across 49 peptides and 150+ genetic insights. This test identifies your natural predispositions and helps your clinician fine-tune whether semaglutide injection is your ideal first choice or whether a dual-compound approach like GLP-Squared might serve your pathway profile better. Genetic personalization removes guesswork and accelerates the path to your best weight-loss outcome.

When Semaglutide May Not Be the Right First Choice

Semaglutide injection isn't appropriate for everyone. Pregnancy, a personal history of thyroid cancer or multiple endocrine neoplasia type 2, and certain gastrointestinal disorders (severe gastroparesis, inflammatory bowel disease) are contraindications. Additionally, if you have a strong family history of medullary thyroid cancer, semaglutide carries a theoretical risk that your clinician must weigh against your weight-loss benefits.

Some people experience nausea, constipation, or appetite loss so severe that adherence becomes impossible—these tolerability issues don't reflect failure but rather misalignment between your physiology and this specific compound. In such cases, oral semaglutide ($249/mo), tirzepatide injection ($249/mo), or a microdose GLP-1 protocol ($129/mo) may work better. PlexusDx clinicians can pivot your therapy based on real-world response, ensuring you find a medication and dosing strategy that fits your body and life.

How PlexusDx Confirms Your Semaglutide Candidacy

PlexusDx begins with a detailed online health intake form capturing your BMI, medical history, current medications, and weight-loss attempts. A licensed clinician then reviews your profile, screens for contraindications, and confirms that semaglutide injection serves your health goals. This process takes 24-48 hours and requires no insurance, no membership fee, and costs just $149 per month for your first-tier compounded semaglutide injection from licensed 503A pharmacies.

HSA and FSA accounts cover PlexusDx medications, making personalized GLP-1 therapy accessible across all 50 states. Once approved, your semaglutide arrives within 3-5 business days with detailed injection training, dose-escalation guidance, and access to your care team. Your dose may increase over weeks or months—your price won't. PlexusDx remains at $149/mo flat, removing cost uncertainty from your weight-loss journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What BMI do I need to qualify for semaglutide injection from PlexusDx?

PlexusDx serves patients with a BMI of 30 or higher, or 27 or higher with a weight-related condition (diabetes, hypertension, sleep apnea, cardiovascular disease). Your clinician confirms eligibility during your intake review; no insurance or prior authorization is required.

How much weight can I expect to lose on semaglutide injection?

Clinical trials show average weight loss of 10-22% of body weight over 68 weeks, with some individuals losing 25% or more. Your genetics, adherence, diet quality, and activity level all influence your personal outcome. PlexusDx offers the Precision Peptide Genetic Test to predict your pathway response and optimize therapy for your genes.

Why does semaglutide cost $149 per month at PlexusDx regardless of my dose?

PlexusDx uses flat monthly pricing ($149/mo for semaglutide injection starting tier) so your cost stays the same as your dose increases—removing financial barriers to reaching your therapeutic dose. This pricing model makes personalized compounded GLP-1 therapy more predictable and affordable than traditional dose-ladder systems.

What are the most common side effects of semaglutide injection, and who should avoid it?

Nausea, constipation, and reduced appetite occur in 20-40% of users and typically subside within 2-4 weeks. Avoid semaglutide if you have a history of thyroid cancer, medullary thyroid carcinoma, or multiple endocrine neoplasia type 2. Pregnancy, severe gastroparesis, and inflammatory bowel disease are also contraindications your PlexusDx clinician will screen for.

How does the Precision Peptide Genetic Test help me decide on semaglutide?

The Precision Peptide Genetic Test ($99 add-on) analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways to predict your semaglutide response strength. If your genes show strong GLP1R sensitivity but FTO risk, your clinician may start you with semaglutide. If results suggest poor GLP-1 pathway activation, tirzepatide or dual GLP-Squared might be your better first choice.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.